Navigation Links
ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
Date:3/31/2008

towards enhanced recanalization of the occluded artery in treated subjects versus controls."

Following a comprehensive review of this program and taking into consideration the challenging financial market conditions, ImaRx's Board of Directors and management concluded that it is in the best interests of the Company and its shareholders to actively seek strategic alternatives for the funding and future development of its SonoLysis technology.

"Based on the encouraging results that were demonstrated in the first cohort of our TUCSON study, we believe that our SonoLysis technology remains an attractive development opportunity in ischemic stroke", stated Bradford A. Zakes. "We are actively evaluating options that will secure funding for the development of this technology while preserving the opportunity for our shareholders to realize significant value from our SonoLysis program."

Urokinase Business Update

Urokinase, the Company's first FDA-approved commercially available product is indicated for the treatment of acute massive pulmonary embolism. Formerly marketed as Abbokinase(R), the FDA approved ImaRx's request to market the product under a new trade name, Kinlytic. The Company acquired urokinase and all related assets, including an approximate four-year supply of inventory, from Abbott Laboratories (NYSE: ABT) in April 2006.

The Company commenced sales of urokinase in October 2006 and experienced consistent hospital pull-through in 2007. In order to continue selling product, the Company has maintained an ongoing stability testing program to support extending the expiration dating of the urokinase inventory. In October 2007, results from the stability testing program successfully met all of the required specifica
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
2. ImaRx to Report Corporate Updates and 4Q07 Financial Results
3. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
6. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
7. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
8. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
9. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
10. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
11. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...4 Favrille, Inc.,(OTC B.... ("MMR"), a health,information company focused o...,Health Records (PHRs), announced today that two s... their definitive merger agreement have been met. ...rnh/20080404/LAF521LOGO ) , "We are pleased...
(Date:12/4/2008)... Fla., Dec. 4 Imaging Di...), a pioneer in laser optical breast,imaging, ann...system as an,adjunct to mammography is featured i..., (Logo: http://www.newscom.com/cgi-bin/p..., MD, a radiologist at Charite Hospital in Berlin,...
(Date:12/4/2008)...nce, Dec. 4 A 60-year-ol...come the first person in France,to be treated usi...tems,(NYSE: VAR ) for fast and precise forms of... his treatments at the CRLC Val D,Aurelle - Paul L... times faster than conventional IMRT,treatments. ...
(Date:12/4/2008)...c. 4 Parion Sciences, Inc. today a...q: GILD ), has initiated a Phase I,clinical tri... safety and,tolerability of the investigational c...ydration for the treatment of pulmonary disease. ...l sodium channel (ENaC) blocker discovered by,Par...
Breaking Biology Technology:Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 2Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 4Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 5Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3
... In research and industrial work it is quite often...e free of protease activity. Using commercially av...ease activity can be measured with the new fluorom... VICTOR is a new multitechnology and multilabe..., photometric and luminescent labels as well as DE...
... , Introduction , DataMax is ...instruments. DataMax can present the measurements ...ap displays multifiles or 3-D data, and looks much...l, or a meteorological plot of barometric pressure...d z values are on the vertical axis. Y values use ...
... , Introduction , The bright...snorkeling so enjoyable when vacationers stay in t... survival of many species of fish and underwater l...er fish to hide from the larger predators, but als...hemselves. Reefs offer protection to plants and an...
..., Introduction , One of the fas...y is concerned with a new generation of graphic di...vision sets. For phosphors that might be used as t...aracteristics are the lifetimes and wavelengths of...nd Results , Because the lifetimes and wav...
Other Biology Technology:Fluorescence assay for determination of protease activity 2Obtaining a contour map from multifiles or 3D data in DataMax 2Obtaining a contour map from multifiles or 3D data in DataMax 3Fluorescent pigments in living coral 2Fluorescent pigments in living coral 3
(Date:12/3/2008)...BIO-key International, Inc.,(OTC Bulletin Board: ...cation,and wireless public safety, announced toda...pproved the issuance of a patent for the company,s...curity System" method. , The benefits of th...er,7,454,624) provide another layer of defense ag...
(Date:12/3/2008)...t 5-year forest inventory report for Oregon,s priv...c: Oregon,s Forest Resources, 2001-2005: Five-Year...e some key findings from the report:, , Oregon,...of Oregon,s total land area of 61 million acres. ,...ticularly near urban areas. The rate of conversion...
(Date:12/3/2008)...ted States continues to develop alternative energy...lulosic-based ethanol has emerged as one of the mo...emains the most popular source available, but the ...the removal of corn fodder as a cellulosic ethanol...ncern. , In the November-December 2008 issue o...
(Date:12/3/2008)...st tandem mission between ERS-2 and Envisat last y...ain to help improve our understanding of the plane...t, the largest environmental satellite ever built,...ents that provide high resolution images of the Ea...ages of the same site, slight alterations that may...
Breaking Biology News(10 mins):BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Managing carbon loss 2ESA satellites flying in formation 2Vgo Software First to Convert Oracle Forms to Oracle ADF v11 26495 1Vgo Software First to Convert Oracle Forms to Oracle ADF v11 26495 2Vgo Software First to Convert Oracle Forms to Oracle ADF v11 26495 3New Bisphenol A Study Has Limited Capability to Assess Human Health Effects 3070 1New Bisphenol A Study Has Limited Capability to Assess Human Health Effects 3070 2Stem cells may solve mystery of early pregnancy breast cancer protection 4910 1Stem cells may solve mystery of early pregnancy breast cancer protection 4910 2Compound Reverses Huntingtons Symptoms in Mice 26489 1Compound Reverses Huntingtons Symptoms in Mice 26489 2
...tic amphibians developed the ability to feed on la... life, researchers from Harvard University report ...my of Sciences. , Their work is based on analysis ... 375 million years ago, and their fish ancestors. ... bones -- termed "sutures" -- in the tops of these...
...ge outbreaks of Ebola virus killed tens of thousan...e? Observations published in the May issue of The ...that outbreaks may be amplified by Ebola transmiss...hope that newly developed vaccines could control t...rect encounters between gorilla or chimpanzee soci...
...ge could trigger "boom and bust" population cycles...ction. , according to Christopher C. Wilmers, an a... University of California, Santa Cruz. , Favorable...pplies of food and stimulate population booms appe...cur when several "good years" in a row are followe...
...have decoded the genetic makeup of the parasite th...exually transmitted infections (STIs), revealing p...ncreasingly drug resistant and suggesting possible...tential vaccine strategy. The genome sequencing pr... and Infectious Diseases (NIAID), part of the Nati...
Other Biology News:Ancient amphibians evolved a bite before migrating to dry land 2Ebola outbreaks killing thousands of gorillas and chimpanzees 2Scientists sequence genome of parasite responsible for common sexually transmitted infection 2Scientists sequence genome of parasite responsible for common sexually transmitted infection 3
Mouse anti-Yersinia pestis F1 antigen, Monoclonal Antibody, Unconjugated Applications: ELISA: Use at an assay dependent dilution. IF: Use at an assay dependent dilution. WB: Use at an assay depe
...edium is specifically formulated for mounting tiss...e been stained with immunohistochemical methods fo... with chromogens, such as AEC, that are alcohol-so...ount dries completely when slides are cover-slippe...
... Vision Mount is formulated for covering tissue s...y stained with chromogens producing alcohol solubl... Application: Vision Mount can be us...quire an aqueous mounting medium, or those that do...
...t polyclonal to JNK1 (phospho T183 + Y185) Immuno...in containing phosphorylated T183/Y185. Reactivit...d Rat. Not yet tested in other species. Backgroun...roups, including the ERK, JNK, and p38 kinases. Th...
Biology Products: